{
  "ptid_time": "127_S_4210_2011-09-08",
  "img_path": "/data/qiuhui/data/adni/images/127_S_4210/2011-09-08/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 12,948 mm³, 56.9% below the reference mean. With a Z-score of -1.35 (8.8th percentile), this represents mild atrophy; hippocampal volume measures 9,229 mm³, 15.0% above the reference mean. With a Z-score of 1.50 (93.3th percentile), this represents mild enlargement; whole brain volume measures 1,228,210 mm³, 8.3% above the reference mean. With a Z-score of 1.17 (87.9th percentile), this represents mild enlargement; entorhinal cortex volume measures 4,253 mm³, 0.2% below the reference mean. With a Z-score of -0.02 (49.4th percentile), this represents normal volume ; fusiform gyrus volume measures 21,999 mm³, 10.5% above the reference mean. With a Z-score of 0.87 (80.9th percentile), this represents normal volume ; middle temporal gyrus volume measures 20,620 mm³, 8.0% below the reference mean. With a Z-score of -0.66 (25.5th percentile), this represents normal volume . ",
  "text_data": "Age is 63.9 years. Gender is Male. Education: 18 years. Handedness: Right. Race: White. Medical history: Head, Eyes, Ears, Nose and Throat; Cardiovascular; Musculoskeletal. MMSE: 29.0. MoCA: 22.0. Logical Memory: 5.0. Laboratory findings: Eosinophils: 0.44 (profound elevated); Basophils: 0.09 (significant elevated); Eosinophils: 6.60 (significant elevated); Basophils: 1.40 (significant elevated); Creatine Kinase: 200.00 (significant elevated); Triglycerides (GPO): 236.00 (significant elevated). APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.01 SUVR (normal ); Total tau: 309.30 pg/mL (normal ); Phosphorylated tau: 30.06 pg/mL (mild elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The brain volume data shows mild ventricular enlargement (suggesting mild atrophy) but otherwise normal or even slightly enlarged volumes in key regions like the hippocampus and whole brain. The MMSE is normal (29/30), but the MoCA (22/30) suggests mild cognitive impairment. APOE4 carrier status and mildly elevated P-tau may indicate early neurodegenerative changes, but AV45 (amyloid PET) is normal, making Alzheimer's less likely.  \n\n**Diagnosis:** **MCI (Mild Cognitive Impairment)**  \n**Confidence:** **Medium** (MoCA suggests impairment, but imaging and amyloid biomarkers are not strongly supportive of dementia or Alzheimer's pathology at this stage.)",
  "timestamp": "2025-07-26T13:16:04.879521"
}